ArticleESMO gastrointestinal oncology2026

Single-system outcomes after adopting yttrium-90 radioembolization with personalized dosimetry as the primary treatment approach for unresectable, solitary hepatocellular carcinoma.

A Zamani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.